Vascepa, a prescription medication containing icosapent ethyl, is used to lower triglycerides in adults with severe hypertriglyceridemia. As a branded medication, its cost is typically higher than generic alternatives.

According to Drugs.com, Vascepa's average retail price in the United States ranges from $600 to $800 per month, depending on the dosage and the pharmacy [1]. This price is often covered by insurance, but out-of-pocket costs may vary.

In contrast, generic or biosimilar versions of icosapent ethyl may offer more affordable options. Although no generic versions of Vascepa are currently available on the market [2], biosimilars or generic versions of similar medications like Lovaza (omega-3-acid ethyl esters) can provide alternatives.

Lovaza's generic version, omega-3-acid ethyl esters, has a lower price point. The average cost of Lovaza can be found around $100-$300 per month for a similar dosage to Vascepa [3], depending on the dosage and pharmacy. However it's essential to note that Lovaza is used for a slightly different indication, primarily for hypertriglyceridemia and not for severe cases as with Vascepa [4].

As research and development of generic or biosimilar versions of Vascepa continue, prices may decrease, making it more affordable for patients. It's recommended to consult with a healthcare professional or a pharmacist for personalized information on pricing and availability of these medications.

Sources:

[1] Drugs.com. Vascepa cost. Retrieved from https://www.drugs.com/price-guide/vascepa

[2] DrugPatentWatch.com. No generic or biosimilar versions of 'Vascepa' found. Retrieved from https://www.drugpatentwatch.com/patent/US10201162?as=2

[3] Drugs.com. Lovaza cost. Retrieved from https://www.drugs.com/price-guide/lovaza

[4] Drugs.com. Lovaza. Retrieved from https://www.drugs.com/lova